Skip navigation Consumer Fund Healthcare Info & Comm Technology Internet & Digital Media

Helicos BioSciences

Helicos BioSciences is a life-science company committed to developing instruments and reagents for the high speed sequencing of single DNA and RNA molecules. High speed sequencing is a breakthrough tool for solving many important and difficult problems in biology and medicine. Helicos BioSciences’ technology will allow cancer researchers to fully and accurately characterize the cancer genome on tens of thousands of tumors, thereby elucidating the full range of molecular alterations which cause cancer, leading to a new era in cancer diagnosis and therapy.

Recent News

Helicos BioSciences Corporation Announces Appointment of Ivan Trifunovich as President and CEO

Helicos Announces the Sale of a System to the Turku Centre for Biotechnology

Helicos BioSciences Provides Strategic Update

Ontario Institute for Cancer Research Takes Delivery of a Helicos(TM) Genetic Analysis System

Massachusetts General Hospital Cancer Center Takes Delivery of a Helicos(TM) Genetic Analysis System

Helicos BioSciences Announces the Sale of a Helicos(TM) Genetic Analysis System

Helicos BioSciences Announces Publication in Nature Methods